Chemoinformaics analysis of (Z)-DEC-4-EN-1-OL
| Molecular Weight | 156.269 | nRot | 7 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 22 |
| Exact Molecular Weight | 156.151 | nRing | 0 |
| Solubility: LogS | -4.584 | nHRing | 0 |
| Solubility: LogP | 3.023 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 30.8379 |
| nHD | 1 | BPOL | 20.0641 |
| QED | 0.694 |
| Synth | 2.842 |
| Natural Product Likeliness | 0.524 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.987 |
| Pgp-sub | 0.009 |
| HIA | 0.003 |
| CACO-2 | -5.028 |
| MDCK | 0.0000387 |
| BBB | 0.978 |
| PPB | 0.900269 |
| VDSS | 2.202 |
| FU | 0.0451708 |
| CYP1A2-inh | 0.912 |
| CYP1A2-sub | 0.952 |
| CYP2c19-inh | 0.114 |
| CYP2c19-sub | 0.948 |
| CYP2c9-inh | 0.025 |
| CYP2c9-sub | 0.857 |
| CYP2d6-inh | 0.762 |
| CYP2d6-sub | 0.947 |
| CYP3a4-inh | 0.873 |
| CYP3a4-sub | 0.87 |
| CL | 11.682 |
| T12 | 0.241 |
| hERG | 0.669 |
| Ames | 0.07 |
| ROA | 0.856 |
| SkinSen | 0.725 |
| Carcinogencity | 0.579 |
| EI | 0.011 |
| Respiratory | 0.953 |
| NR-Aromatase | 0.088 |
| Antiviral | No |
| Prediction | 0.91695 |